Thalassemia Reports (Jan 2023)

Cardiovascular Complications in β-Thalassemia: Getting to the Heart of It

  • Nathalie Akiki,
  • Mohammad H. Hodroj,
  • Rayan Bou-Fakhredin,
  • Kamal Matli,
  • Ali T. Taher

DOI
https://doi.org/10.3390/thalassrep13010005
Journal volume & issue
Vol. 13, no. 1
pp. 38 – 50

Abstract

Read online

Beta thalassemia is an inherited disorder resulting in abnormal or decreased production of hemoglobin, leading to hemolysis and chronic anemia. The long-term complications can affect multiple organ systems, namely the liver, heart, and endocrine. Myocardial iron overload is a common finding in β-thalassemia. As a result, different cardiovascular complications in the form of cardiomyopathy, pulmonary hypertension, arrhythmias, and vasculopathies can occur, and in extreme cases, sudden cardiac death. Each of these complications pertains to underlying etiologies and risk factors, which highlights the importance of early diagnosis and prevention. In this review, we will discuss different types of cardiovascular complications that can manifest in patients with β-thalassemia, in addition to the current diagnostic modalities, preventive and treatment modalities for these complications.

Keywords